We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Polyvinyl Chloride Promotes Radioresistance in Hepatocellular Carcinoma by Inhibiting Radiotherapy-Induced CD8⁺ T Cell Differentiation
Summary
This is a duplicate entry of the same study (also listed as ID 2583) finding that polyvinyl chloride microplastics were present in 72% of human liver cancer tumors and that PVC inhibits the immune response to radiotherapy by disrupting cholesterol metabolism in CD8+ T cells, potentially undermining cancer treatment outcomes.
Radiotherapy (RT) has emerged as one of the primary treatment modalities for intermediate and advanced hepatocellular carcinoma (HCC). However, RT resistance remains widespread. Microplastics (MPs) have been detected in various tumors and may disrupt immune responses. However, evidence regarding the role of MPs in RT is scarce. Several MPs were identified in 72% (52/72) of HCC samples, among which polyvinyl chloride (PVC) impaired RT efficacy. Mechanistically, RT enhanced histone lactylation, which promoted the transcription of HMG-CoA reductase in HCC cells, thereby facilitating cholesterol synthesis and reinforcing CD8+ T cell stemness. PVC altered cholesterol localization and affected CD8⁺ T cell differentiation, which maintained a ‘cold’ tumor immune microenvironment (TIME). A high-cholesterol diet restored CD8+ T-cell stemness and improved the therapeutic response to RT in PVC-infiltrated HCC. We demonstrated that PVC could promote RT resistance. Targeting cholesterol metabolism may represent a potential combinatorial strategy to enhance the efficacy of RT in PVC-infiltrated HCC.